9th Circ. Skeptical Calif. Pay-For-Delay Law Poses Danger

Law360 (July 16, 2020, 7:39 PM EDT) -- A Ninth Circuit panel on Thursday pressed the attorney for a generic-drug industry association during oral arguments to explain how California's state law prohibiting most so-called pay-for-delay settlements poses a risk of imminent danger to pharmaceutical companies.

The Association for Accessible Medicines is appealing the district court's New Year's Eve decision rejecting the group's bid for a preliminary injunction that would block implementation of A.B. 824, which the governor signed into law in October last year.

The statute is the first in the nation to directly target pay-for-delay deals and makes it presumptively illegal for branded drug companies to reach patent...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!